<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">helmholtzeyeinstitute</journal-id><journal-title-group><journal-title xml:lang="ru">Российский офтальмологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Ophthalmological Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0076</issn><issn pub-type="epub">2587-5760</issn><publisher><publisher-name>Real time Publishers</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21516/2072-0076-2021-14-3-19-24</article-id><article-id custom-type="elpub" pub-id-type="custom">helmholtzeyeinstitute-714</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Электрофизиологические маркеры развитых стадий глаукомной оптической нейропатии</article-title><trans-title-group xml:lang="en"><trans-title>Electrophysiological markers of advanced stages of glaucomatous optic neuropathy</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4675-9648</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Котелин</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Kotelin</surname><given-names>V. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p> аспирант отдела глаукомы </p><p>ул. Садовая-Черногрязская, д. 14/19, Москва, 105062, Россия </p></bio><bio xml:lang="en"><p> PhD student, Glaucoma Department</p><p> 14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062, Russia </p></bio><email xlink:type="simple">vikotelin@ya.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0161-5010</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зуева</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zueva</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p> д-р биол. наук, профессор, начальник отдела клинической физиологии зрения им. С.В. Кравкова </p><p>ул. Садовая-Черногрязская, д. 14/19, Москва, 105062, Россия </p></bio><bio xml:lang="en"><p> Dr. of Biol. Sci., professor, head of department of clinical physiology of vision named after S.V. Kravkov</p><p> 14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062, Russia  </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0148-8517</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Цапенко</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tsapenko</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p> канд. биол. наук, старший научный сотрудник отдела клинической физиологии зрения им. С.В. Кравкова </p><p>ул. Садовая-Черногрязская, д. 14/19, Москва, 105062, Россия </p></bio><bio xml:lang="en"><p> Cand. of Biol. Sci., senior researcher, department of clinical physiology of vision named after S.V. Kravkov</p><p> 14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062, Russia </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6922-0464</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петров</surname><given-names>С. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Petrov</surname><given-names>S. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p> д-р мед. наук, начальник отдела глаукомы </p><p>ул. Садовая-Черногрязская, д. 14/19, Москва, 105062, Россия </p></bio><bio xml:lang="en"><p> Dr. of Med. Sci., head of glaucoma department</p><p> 14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062, Russia </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8381-2124</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Журавлева</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhuravleva</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p> канд. мед. наук, научный сотрудник отдела глаукомы </p><p> ул. Садовая-Черногрязская, д. 14/19, Москва, 105062, Россия </p></bio><bio xml:lang="en"><p> Cand. of Med. Sci., researcher, glaucoma department</p><p> 14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062, Russia </p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «НМИЦ глазных болезней им. Гельмгольца» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Helmholtz National Medical Research Center of Eye Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>10</day><month>09</month><year>2021</year></pub-date><volume>14</volume><issue>3</issue><fpage>19</fpage><lpage>24</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Котелин В.И., Зуева М.В., Цапенко И.В., Петров С.Ю., Журавлева А.Н., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Котелин В.И., Зуева М.В., Цапенко И.В., Петров С.Ю., Журавлева А.Н.</copyright-holder><copyright-holder xml:lang="en">Kotelin V.I., Zueva M.V., Tsapenko I.V., Petrov S.Y., Zhuravleva A.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://roj.igb.ru/jour/article/view/714">https://roj.igb.ru/jour/article/view/714</self-uri><abstract><p>Цель — определить изменения электрофизиологических показателей, отражающих специфические нарушения функции ганглиозных клеток сетчатки (ГКС) на развитых стадиях глаукомной оптической нейропатии (ГОН).</p><sec><title>Материал и методы</title><p>Материал и методы. В исследовании приняли участие 35 пациентов (55 глаз) в возрасте 51–76 лет (63,1 ± 7,7 года) с первичной открытоугольной глаукомой (ПОУГ), предварительно разделенных на две подгруппы: с ПОУГ развитой (24 пациента, 27 глаз) и далеко зашедшей стадиями (24 пациента, 28 глаз). Сравнимая по возрасту контрольная группа (51–72 года, 59,8 ± 5,9 года) включала 28 относительно здоровых лиц (32 глаза). Регистрировали транзиентную и стационарную паттерн-электроретинограмму (ПЭРГ) и фотопический негативный ответ (ФНО) по стандартам ISCEV.</p></sec><sec><title>Результаты</title><p>Результаты. Установлено снижение амплитуд волн N95 и Р50 транзиентной ПЭРГ и стационарной ПЭРГ, степень которого обратно зависела от углового размера стимула, что резко отличало развитые стадии ПОУГ от начальной ГОН. Развитые стадии характеризуются снижением амплитуды ФНО, рассчитанной от изолинии, и индекса ФНО/b. Угнетение этих показателей тем значительнее, чем больше сила вспышки. Установлено значительное по сравнению с возрастной нормой удлинение пиковой латентности N95 для паттернов всех угловых размеров и менее выраженное удлинение латентности волны Р50, значимое только для мелких стимулов (0,8° и 0,3°). Латентности стационарной ПЭРГ и ФНО практически не отличались от значений возрастной нормы.</p></sec><sec><title>Заключение</title><p>Заключение. Выявленная редукция амплитуды волн N95 и Р50 транзиентной и стационарной ПЭРГ, ФНО и индекса ФНО/b, а также удлинение пиковой латентности волн N95 и P50 транзиентной ПЭРГ могут являться маркерами функциональных изменений в сетчатке, связанными с неадаптивной пластичностью или отражающими комбинацию процессов адаптивной пластичности и дегенерации ГКС. Дальнейшие исследования в этой области позволят дать более точную характеристику найденным закономерностям и применить полученные результаты в клинической практике.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Purpose</title><p>Purpose: to determine the changes in electrophysiological parameters reflecting specific dysfunctions of retinal ganglion cells (RGCs) at advanced stages of glaucomatous optic neuropathy (GON).</p></sec><sec><title>Material and methods</title><p>Material and methods. The study involved 35 patients (55 eyes) aged 51–76 (63.1 ± 7.7 years) with primary open-angle glaucoma (POAG), divided into two subgroups depending on POAG stages: developed (24 patients, 27 eyes) and advanced stages (24 patients, 28 eyes). The age-matched control group (aged 51–72, 59.8 ± 5.9) included 28 relatively healthy individuals (32 eyes). Transient and steady-state pattern ERG (PERG) and photopic negative response (PhNR) were recorded according to ISCEV standards.</p></sec><sec><title>Results</title><p>Results. A decrease in the amplitude of the transient PERG's N95 and P50-waves and steady-state PERG was found, the degree of which showed an inverse dependence on the angular size of the stimulus, which clearly distinguished the developed and advanced POAG stages from the initial GON. The developed stages are characterized by a decrease in the PhNR amplitude, calculated from the baseline, and the PhNR/b index, the reduction of which was the more significant the greater the intensity of the flash. A significant delay of the N95 peak for patterns of all angular sizes and a less pronounced lengthening of the latency of the P50 wave (significant only for small stimuli 0.8° and 0.3°) in comparison with the age norm were found. The latencies of the steady-state PERG and PhNR practically did not differ from the age norm values.</p></sec><sec><title>Conclusion</title><p>Conclusion. The revealed reduction in the amplitudes of N95 and P50 waves of transient and steady-state PERG, PhNR, and the PhNR/b index, as well as an increase in the peak latency of N95 and P50 waves of transient PERG, may be markers of functional changes in the retina associated with non-adaptive plasticity or reflecting a combination of the processes of adaptive plasticity and degeneration of RGCs. Further research in this area will help give a more accurate characterization of the found regularities and apply the obtained results in clinical practice.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>развитые стадии первичной открытоугольной глаукомы</kwd><kwd>глаукомная оптическая нейропатия</kwd><kwd>паттерн-ЭРГ</kwd><kwd>фотопический негативный ответ</kwd><kwd>клинически значимые биомаркеры</kwd></kwd-group><kwd-group xml:lang="en"><kwd>advanced stages of primary open-angle glaucoma</kwd><kwd>glaucomatous optic neuropathy</kwd><kwd>pattern-ERG</kwd><kwd>photopic negative response</kwd><kwd>clinically significant biomarkers</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Tham Y.C., Li X., Wong T.Y., et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014; 121 (11): 2081–90. doi: 10.1016/j.ophtha.2014.05.013</mixed-citation><mixed-citation xml:lang="en">Tham Y.C., Li X., Wong T.Y., et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014; 121 (11): 2081–90. doi: 10.1016/j.ophtha.2014.05.013</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Нероев В.В., Зуева М.В., Журавлева А.Н., Цапенко И.В. Структурнофункциональные нарушения при глаукоме: перспективы доклинической диагностики. Часть 2. Электрофизиологические маркеры ранних нейропластических событий. Офтальмология. 2020; 17 (3s): 533–41. https://doi.org/10.18008/1816-5095-2020-3S-533-541</mixed-citation><mixed-citation xml:lang="en">Neroev V.V., Zueva M.V., Zhuravleva A.N., Tsapenko I.V. Structural and functional disorders in glaucoma: prospects for preclinical diagnosis. Part 2. Electrophysiological markers of early neuroplastic events. Ophthalmology in Russia. 2021; 17 (3s): 533–41 (in Russian). https://doi.org/10.18008/1816-5095-2020-3S-533-541</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Кириллова М.О., Зуева М.В., Цапенко И.В., Журавлева А.Н. Электрофизиологические маркеры доклинической диагностики глаукомной оптической нейропатии. Российский офтальмологический журнал. 2021; 14 (1): 35–41. https://doi.org/10.21516/2072-0076-2021-14-1-35-41</mixed-citation><mixed-citation xml:lang="en">Kirillova M.O., Zueva M.V., Tsapenko I.V., Zhuravleva A.N.Electrophysiological markers of preclinical diagnosis of glaucomatous optic neuropathy. Russian ophthalmological journal. 2021; 14 (1): 35–41 (In Russian). https://doi.org/10.21516/2072-0076-2021-14-1-35-41</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Sommer A., Katz J., Quigley H.A., et al. Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss. Arch. Ophthalmol. 1991; 109 (1): 77–83. doi: 10.1001/archopht.1991.01080010079037</mixed-citation><mixed-citation xml:lang="en">Sommer A., Katz J., Quigley H.A., et al. Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss. Arch. Ophthalmol. 1991; 109 (1): 77–83. doi: 10.1001/archopht.1991.01080010079037</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Hood D.C., Kardon R.H. A framework for comparing structural and functiona measures of glaucomatous damage. Prog. Retin. Eye Res. 2007; 26 (6): 688–710. https://doi.org/10.1016/j.preteyeres.2007.08.001</mixed-citation><mixed-citation xml:lang="en">Hood D.C., Kardon R.H. A framework for comparing structural and functiona measures of glaucomatous damage. Prog. Retin. Eye Res. 2007; 26 (6): 688–710. https://doi.org/10.1016/j.preteyeres.2007.08.001</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Mwanza J.C., Chang R.T., Budenz D.L., et al. Reproducibility of peripapillary retinal nerve fiber layer thickness and optic nerve head parameters measured with cirrus HDOCT in glaucomatous eyes. Invest. Ophthalmol. Vis. Sci. 2010; 51 (11): 5724–730. doi: 10.1167/iovs.10-5222</mixed-citation><mixed-citation xml:lang="en">Mwanza J.C., Chang R.T., Budenz D.L., et al. Reproducibility of peripapillary retinal nerve fiber layer thickness and optic nerve head parameters measured with cirrus HDOCT in glaucomatous eyes. Invest. Ophthalmol. Vis. Sci. 2010; 51 (11): 5724–730. doi: 10.1167/iovs.10-5222</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang X., Dastiridou A., Francis B.A., et al. On behalf of the Advanced Imaging for Glaucoma Study Group. Comparison of glaucoma progression detection by optical coherence tomography and visual field. Am. J. Ophthalmol. 2017; 184: 63–74. doi:10.1016/j.ajo.2017.09.020</mixed-citation><mixed-citation xml:lang="en">Zhang X., Dastiridou A., Francis B.A., et al. On behalf of the Advanced Imaging for Glaucoma Study Group. Comparison of glaucoma progression detection by optical coherence tomography and visual field. Am. J. Ophthalmol. 2017; 184: 63–74. doi:10.1016/j.ajo.2017.09.020</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Gupta N., Yücel Y. Glaucoma as a neurodegenerative disease. Curr. Opin. Ophthalmol. 2007 Mar; 18 (2): 110–4. doi: 10.1097/ICU.0b013e3280895aea</mixed-citation><mixed-citation xml:lang="en">Gupta N., Yücel Y. Glaucoma as a neurodegenerative disease. Curr. Opin. Ophthalmol. 2007 Mar; 18 (2): 110–4. doi: 10.1097/ICU.0b013e3280895aea</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Calkins D.J. Critical pathogenic events underlying progression of neurodegeneration in glaucoma. Prog. Retin. Eye Res. 2012; 31, 702–19. doi: 10.1016/j.preteyeres.2012.07.001</mixed-citation><mixed-citation xml:lang="en">Calkins D.J. Critical pathogenic events underlying progression of neurodegeneration in glaucoma. Prog. Retin. Eye Res. 2012; 31, 702–19. doi: 10.1016/j.preteyeres.2012.07.001</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Зуева М.В. Динамика гибели ганглиозных клеток сетчатки при глаукоме и ее функциональные маркеры. Национальный журнал глаукома. 2016; 15 (1): 70–85.</mixed-citation><mixed-citation xml:lang="en">Zueva M.V. Dynamics of retinal ganglion cell death in glaucoma and its functional markers. Russian journal of glaucoma. 2016; 15 (1): 70–85 (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ly T., Gupta N., Weinreb R.N., Kaufman P.L., Yücel Y.H. Dendrite plasticity in the lateral geniculate nucleus in primate glaucoma. Vis. Res. 2011; 51 (2): 243–50. https://doi.org/10.1016/j.visres.2010.08.003</mixed-citation><mixed-citation xml:lang="en">Ly T., Gupta N., Weinreb R.N., Kaufman P.L., Yücel Y.H. Dendrite plasticity in the lateral geniculate nucleus in primate glaucoma. Vis. Res. 2011; 51 (2): 243–50. https://doi.org/10.1016/j.visres.2010.08.003</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Shou T., Liu J., Wang W., Zhou Y., Zhao K. Differential dendritic shrinkage of alpha and beta retinal ganglion cells in cats with chronic glaucoma. Invest. Ophthalmol. Vis. Sci. 2003; 44: 3005–10. https://doi.org/10.1167/iovs.02-0620</mixed-citation><mixed-citation xml:lang="en">Shou T., Liu J., Wang W., Zhou Y., Zhao K. Differential dendritic shrinkage of alpha and beta retinal ganglion cells in cats with chronic glaucoma. Invest. Ophthalmol. Vis. Sci. 2003; 44: 3005–10. https://doi.org/10.1167/iovs.02-0620</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Porciatti V., Ventura L.M. Retinal ganglion cell functional plasticity and optic neuropathy: a comprehensive model. J. Neuroophthalmol 2012; 32 (4): 354–8. https://doi.org/10.1097/WNO.0b013e3182745600</mixed-citation><mixed-citation xml:lang="en">Porciatti V., Ventura L.M. Retinal ganglion cell functional plasticity and optic neuropathy: a comprehensive model. J. Neuroophthalmol 2012; 32 (4): 354–8. https://doi.org/10.1097/WNO.0b013e3182745600</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kalesnykas G., Oglesby E.N., Zack D.J., et al. Retinal ganglion cell morphology after optic nerve crush and experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 2012; 53 (7): 3847–57. https://doi.org/10.1167/iovs.12-9712</mixed-citation><mixed-citation xml:lang="en">Kalesnykas G., Oglesby E.N., Zack D.J., et al. Retinal ganglion cell morphology after optic nerve crush and experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 2012; 53 (7): 3847–57. https://doi.org/10.1167/iovs.12-9712</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Della Santina L., Inman D.M., Lupien C.B., Horner P.J., Wong R.O.L. Differential progression of structural and functional alterations indistinct retinal ganglion cell types in a mouse model of glaucoma. J. Neurosci. 2013; 33: 17444–57. doi: 10.1523/JNEUROSCI.5461-12.2013</mixed-citation><mixed-citation xml:lang="en">Della Santina L., Inman D.M., Lupien C.B., Horner P.J., Wong R.O.L. Differential progression of structural and functional alterations indistinct retinal ganglion cell types in a mouse model of glaucoma. J. Neurosci. 2013; 33: 17444–57. doi: 10.1523/JNEUROSCI.5461-12.2013</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Park H.Y., Kim J.H., Park C.K. Alterations of the synapse of the inner retinal layers after chronic intraocular pressure elevation in glaucoma animal model. Mol. Brain. 2014; 7: 53. https://doi.org/10.1186/s13041-014-0053-2</mixed-citation><mixed-citation xml:lang="en">Park H.Y., Kim J.H., Park C.K. Alterations of the synapse of the inner retinal layers after chronic intraocular pressure elevation in glaucoma animal model. Mol. Brain. 2014; 7: 53. https://doi.org/10.1186/s13041-014-0053-2</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">El-Danaf R.N., Huberman A.D. Characteristic patterns of dendritic remodeling in early-stage glaucoma: evidence from genetically identified retinal ganglion cell types. J. Neurosci. 2015, 35 (6): 2329-43. https://doi.org/10.1523/JNEUROSCI.1419-14.2015</mixed-citation><mixed-citation xml:lang="en">El-Danaf R.N., Huberman A.D. Characteristic patterns of dendritic remodeling in early-stage glaucoma: evidence from genetically identified retinal ganglion cell types. J. Neurosci. 2015, 35 (6): 2329-43. https://doi.org/10.1523/JNEUROSCI.1419-14.2015</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Нероев В.В., Зуева М.В., Цапенко И.В. и др. Ишемические аспекты патогенеза заболеваний сетчатки. Российский офтальмологический журнал; 2010; 3 (1): 42–9.</mixed-citation><mixed-citation xml:lang="en">Neroev V.V., Zueva M.V., Tsapenko I.V., et al. Ischemic aspects of the pathogenesis of retinal diseases. Russian ophthalmological journal. 2010; 3 (1): 42–9 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Cuenca N., Fernandez-Sanchez L., Campello L., et al. Cellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseases. Prog. Ret. Eye Res. 2014; 43: 17–75. https://doi.org/10.1016/j.preteyeres.2014.07.001</mixed-citation><mixed-citation xml:lang="en">Cuenca N., Fernandez-Sanchez L., Campello L., et al. Cellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseases. Prog. Ret. Eye Res. 2014; 43: 17–75. https://doi.org/10.1016/j.preteyeres.2014.07.001</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Francardo V., Schmitz Y., Sulzer D., Cenci M.A. Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's disease. Exp. Neurol. 2017; 298: 137–47. https://doi.org/10.1016/j.expneurol.2017.10.001</mixed-citation><mixed-citation xml:lang="en">Francardo V., Schmitz Y., Sulzer D., Cenci M.A. Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's disease. Exp. Neurol. 2017; 298: 137–47. https://doi.org/10.1016/j.expneurol.2017.10.001</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Bach M., Brigell M., Hawlina M., et al. ISCEV standard for clinical pattern electroretinography (PERG). Doc. Ophthalmol. 2013; 126: 1–7. doi.org/10.1007/s10633-012-9353-y</mixed-citation><mixed-citation xml:lang="en">Bach M., Brigell M., Hawlina M., et al. ISCEV standard for clinical pattern electroretinography (PERG). Doc. Ophthalmol. 2013; 126: 1–7. doi.org/10.1007/s10633-012-9353-y</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Frishman L., Sustar M., Kremers J., et al. ISCEV extended protocol for the photopic negative response (PhNR) of the full-field electroretinogram. Doc. Ophthalmol. 2018; 36 (3): 207–11. doi: 10.1007/s10633-018-9638-x</mixed-citation><mixed-citation xml:lang="en">Frishman L., Sustar M., Kremers J., et al. ISCEV extended protocol for the photopic negative response (PhNR) of the full-field electroretinogram. Doc. Ophthalmol. 2018; 36 (3): 207–11. doi: 10.1007/s10633-018-9638-x</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Котелин В.И., Кириллова М.О., Зуева М.В. и др. Фотопический негативный ответ для оценки функции внутренней сетчатки — требования к регистрации и сравнение в глазах с естественной шириной зрачка и в условиях медикаментозного мидриаза. Офтальмология. 2020; 17 (3): 398–406. https://doi.org/10.18008/1816-5095-2020-3-398-406</mixed-citation><mixed-citation xml:lang="en">Kotelin V.I., Kirillova M.O., Zueva M.V., et al. Photopic negative response for testing the function of inner retina — registration requirements and comparison in the eyes with natural pupil width and in conditions of drug mydriasis. Ophthalmology in Russia. 2020; 17 (3): 398–406 (in Russian). https://doi.org/10.18008/1816-5095-2020-3-398-406</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Зуева М.В., Журавлева А.Н., Боголепова А.Н. Дендритное ветвление ганглиозных клеток сетчатки как биомаркер глаукомной оптической нейропатии и болезни Альцгеймера и мишень нейропротекторной терапии. Офтальмология. 2021; 18 (2): 265–75. https://doi.org/10.18008/1816-5095-2021-2-266-275</mixed-citation><mixed-citation xml:lang="en">Zueva M.V., Zhuravleva A.N., Bogolepova A.N. Dendritic branching of retinal ganglion cells as a biomarker of glaucomatous optic neuropathy and Alzheimer's disease and a target of neuroprotective therapy. Ophthalmology in Russia. 2021; 18 (2): 265–75 (in Russian). https://doi.org/10.18008/1816-5095-2021-2-266-275</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Liu M., Duggan J., Salt T.E., Cordeiro M.F. Dendritic changes in visual pathways in glaucoma and other neurodegenerative conditions. Exp. Eye Res. 2011; 92: 244–50. doi: 10.1016/j.exer.2011.01.014</mixed-citation><mixed-citation xml:lang="en">Liu M., Duggan J., Salt T.E., Cordeiro M.F. Dendritic changes in visual pathways in glaucoma and other neurodegenerative conditions. Exp. Eye Res. 2011; 92: 244–50. doi: 10.1016/j.exer.2011.01.014</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Wang H.-L., Xian X.-H., Song Q.-Y., et al. Age-related alterations of neuronal excitability and voltage-dependent Ca2+ current in a spontaneous mouse model of Alzheimer’s disease. Behav. Brain Res. 2017; 321: 209–13. doi: 10.1016/j.bbr.2017.01.009</mixed-citation><mixed-citation xml:lang="en">Wang H.-L., Xian X.-H., Song Q.-Y., et al. Age-related alterations of neuronal excitability and voltage-dependent Ca2+ current in a spontaneous mouse model of Alzheimer’s disease. Behav. Brain Res. 2017; 321: 209–13. doi: 10.1016/j.bbr.2017.01.009</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Kim J., Hughes E.G., Shetty A.S., et al. Changes in the excitability of neocortical neurons in a mouse model of amyotrophic lateral sclerosis are not specific to corticospinal neurons and are modulated by advancing disease. J. Neurosci. 2017; 37: 9037–53. doi: 10.1523/JNEUROSCI.0811-17.2017</mixed-citation><mixed-citation xml:lang="en">Kim J., Hughes E.G., Shetty A.S., et al. Changes in the excitability of neocortical neurons in a mouse model of amyotrophic lateral sclerosis are not specific to corticospinal neurons and are modulated by advancing disease. J. Neurosci. 2017; 37: 9037–53. doi: 10.1523/JNEUROSCI.0811-17.2017</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Turrigiano G. Homeostatic synaptic plasticity: local and global mechanisms for stabilizing neuronal function. Cold Spring Harb. Perspect. Biol. 2012; 4: a005736. doi: 10.1101/cshperspect.a005736</mixed-citation><mixed-citation xml:lang="en">Turrigiano G. Homeostatic synaptic plasticity: local and global mechanisms for stabilizing neuronal function. Cold Spring Harb. Perspect. Biol. 2012; 4: a005736. doi: 10.1101/cshperspect.a005736</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Orr B.O., Hauswirth A.G., Celona B., et al. Presynaptic homeostasis opposes disease progression in mouse models of ALS-like degeneration: evidence for homeostatic neuroprotection. Neuron. 2020; 107: 95.e6–111.e6. doi: 10.1016/j.neuron.2020.04.009</mixed-citation><mixed-citation xml:lang="en">Orr B.O., Hauswirth A.G., Celona B., et al. Presynaptic homeostasis opposes disease progression in mouse models of ALS-like degeneration: evidence for homeostatic neuroprotection. Neuron. 2020; 107: 95.e6–111.e6. doi: 10.1016/j.neuron.2020.04.009</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Van Hook M.J., Monaco C., Bierlein E.R., Smith J.C. Neuronal and synaptic plasticity in the visual thalamus in mouse models of glaucoma. Front. Cell. Neurosci. 2021; 14: 626056. doi: 10.3389/fncel.2020.626056</mixed-citation><mixed-citation xml:lang="en">Van Hook M.J., Monaco C., Bierlein E.R., Smith J.C. Neuronal and synaptic plasticity in the visual thalamus in mouse models of glaucoma. Front. Cell. Neurosci. 2021; 14: 626056. doi: 10.3389/fncel.2020.626056</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Gupta N., Ly T., Zhang Q., et al. Chronic ocular hypertension induces dendrite pathology in the lateral geniculate nucleus of the brain. Exp. Eye Res. 2007; 84: 176–84. doi: 10.1016/j.exer.2006.09.013</mixed-citation><mixed-citation xml:lang="en">Gupta N., Ly T., Zhang Q., et al. Chronic ocular hypertension induces dendrite pathology in the lateral geniculate nucleus of the brain. Exp. Eye Res. 2007; 84: 176–84. doi: 10.1016/j.exer.2006.09.013</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
